Log in to save to my catalogue

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_234aa7b2c810480f9a278f78b977cc88

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents

About this item

Full title

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents

Publisher

Cham: Springer International Publishing

Journal title

BMC chemistry, 2019-07, Vol.13 (1), p.90-22, Article 90

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Benzimidazole is a valuable pharmacophore in the field of medicinal chemistry and exhibit wide spectrum of biological activity. Molecular docking technique is routinely used in modern drug discovery for understanding the drug-receptor interaction. The selected data set of synthesized benzimidazole compounds was evaluated for its in vitro anticancer...

Alternative Titles

Full title

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_234aa7b2c810480f9a278f78b977cc88

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_234aa7b2c810480f9a278f78b977cc88

Other Identifiers

ISSN

2661-801X

E-ISSN

2661-801X

DOI

10.1186/s13065-019-0608-5

How to access this item